| Product Identification | |
|---|---|
| Product Name | Phloroglucinol |
| IUPAC Name | Benzene-1,3,5-triol |
| Chemical Formula | C6H6O3 |
| Synonyms & Trade Names | 1,3,5-Trihydroxybenzene, Phloroglucine; Phenol Reducing Agent (application-dependent in color development chemistry) |
| CAS Number | 108-73-6 |
| HS Code & Customs Classification | The typical HS code assigned is 2907.29 (Phenols; phenol-alcohols, phenol-ethers, phenol-aldehydes, phenol-ketones, phenol-quinones, and their derivatives: Other polyphenols). Selection of the final code often considers country-specific customs interpretation, grade, and declared end use. |
Phloroglucinol production routes can differ by region and customer demand, mainly focusing on multi-step synthesis from resorcinol or trinitrobenzene derivatives. Raw material selection relies on lot traceability and impurity profile, since upstream aromatic impurities contribute to final color bodies and byproduct profiles, especially for applications requiring high purity or pharmaceutical grade material. Selecting the synthesis route is driven by scale economics, effluent profile management, downstream purification compatibility, and overall process safety.
Key production steps include oxidative hydrolysis and controlled reduction to target the 1,3,5-triol ring. Continuous process monitoring plays a role in controlling partial reduction byproducts and maintaining throughput. The fraction of residual mono- or dihydroxybenzene impurities correlates to both reaction conditions and raw material lot variance. Downstream purification utilizes recrystallization and, for high-purity grades, advanced liquid-phase decolorization and solid-phase adsorption, since color consistency is application-sensitive and directly affects suitability for dye and colorimetric reagent users.
Commercial and technical grades differ in color, moisture content, and byproduct profile. Higher grades demand tighter ash content, lower iron, and lower organonitrogen residue. Analytical and pharma/intermediate grades require validated control steps for trace impurity elimination. Some downstream markets, such as diagnostic, pharma, or dye intermediate users, set release criteria for aldehyde, iron, and chloride, which need periodic verification by third-party or in-house quality labs depending on the final application and regulatory zone.
Moisture absorption and sensitivity of phloroglucinol is an important batch handling concern. Standard industrial lots need controlled humidity during packaging, especially in regions with high ambient moisture. Color shift can develop during prolonged ambient storage, linked to trace oxidation and iron catalyzed polymerization. Regular maintenance of air exclusion and desiccated storage practice is prioritized for premium and analytical lots.
Each lot’s release depends on compliance with customer-required assay minimums, colorimetric index, and maximum content of residual dihydroxybenzene components. Analytical confirmation is carried out per batch; formal batch records document both in-process control and final packing lot traceability. The final release standard is subject to internal quality control criteria and customer requirements, with custom test plans for sensitive formulation sectors.
Phloroglucinol generally presents as a white to pale yellow crystalline solid in standard bulk manufacturing. Color strength and appearance may vary with process route and raw material purity, especially if handled in open or humid environments, which can promote mild discoloration. Bulk odor profiles depend on the starting phenolic raw streams and atmospheric exposure during drying, with higher grades processed under inert or dehumidified conditions displaying virtually no perceptible odor.
Melting point reports depend on grade and potential hydrate content. Anhydrous crystalline batches produced under strictly controlled dehumidification tend to show more defined melting characteristics than monohydrate forms, which can appear at lower, less precise melting ranges. Boiling and flash points have limited operational relevance due to the compound’s thermal instability above certain thresholds; most industrial processes avoid transfer or handling at high temperatures. Density values will shift with the degree of hydration, compaction, and form (loose powder, pellet, pressed slab). These factors directly affect handling and dosing in downstream synthesis or formulation.
Industrial experience confirms phloroglucinol exhibits high reactivity due to its multiple hydroxyl groups. Stability depends strongly on exclusion of moisture and air, which can drive slow degradation or color change if storage conditions are breached. Reactivity with strong bases and oxidizers is well documented in production and downstream transformations; runaway exotherms can occur in uncontrolled environments. Material stored under dehumidified, oxygen-excluded atmospheres demonstrates significantly longer shelf stability and lower incident rates during batch handling.
Solubility in water and polar solvents strongly correlates with process purity and degree of crystallinity. Highly purified grades dissolve rapidly in deionized water and neutral pH, forming clear solutions required for pharmaceutical and fine chemical production. Presence of trace tars or higher-molecular-weight byproducts from incomplete purification can limit dissolution and affect final solution clarity. In industrial solution preparation, agitation and water temperature are tightly controlled to limit formation of insolubles and to avoid partial hydrolysis.
| Parameter | Industrial Grade | Pharma Grade |
|---|---|---|
| Appearance | Pale yellow crystalline | White crystalline |
| Assay | Typical values align with regulatory or end-use need | Defined by pharmacopeial/food use standards |
| Loss on Drying | Grade-dependent specification | Lower for injectables/tablet use |
| Heavy Metals | Higher tolerance in general-use grades | PPT level required |
Final specification and release criteria depend on the intended customer application. Grades used in specialty chemicals tolerate higher impurity levels relative to pharmaceutical or analytical grades.
Impurity levels primarily reflect synthesis route, raw material quality, and effectiveness of downstream purification. Major impurities arise from incomplete reaction, side-chain condensation, and carryover from upstream phenolic streams. Heavy metal content must be suppressed through feedstock screening and vessel contamination control. Test methods for trace impurities and degradants follow compendial and customer-mandated reference procedures; results are confirmed batchwise before product release.
Quality testing commonly includes titrimetric assay, HPLC impurity profile, water content by Karl Fischer method, and spectrophotometric identification. Detailed method selection responds to product grade and downstream validation requirements. In-process samples are monitored to pre-empt specification drift; final product is released on finished batch retest.
Selection of raw phenolic feedstocks prioritizes consistent supply and traceability. For sensitive applications, starting streams are tested for halogenated or aromatic impurities prior to main synthesis. Cost, regional regulatory compliance, and impurity burden drive route selection over technical efficiency alone.
Phloroglucinol is produced through multiple routes: reduction of phloroacetophenone, hydrolysis of hexamethylenetetramine/phenol condensation intermediates, or direct trinitrobenzene reduction. Reagent choice and batch configuration depend on cost, process scalability, and environmental considerations for waste treatment. Each route generates a predictable impurity pattern, which is mapped for targeted downstream removal.
Critical points include pH management, temperature ramp rate, and controlled addition times for reducing agents or acid quench steps. Filtration, washing, and controlled recrystallization remove tars and colored byproducts. Incomplete purification leads to persistent color bodies and odor even after drying. Continuous monitoring of intermediate quality ensures reproducibility and final specification attainment.
Each batch undergoes interim stage sampling and final lot analysis for appearance, assay, water, and impurity levels. Batches failing critical parameters are segregated for additional processing or down-graded based on re-qualification. Final batch release conforms to customer specification and internal release limits reviewed per lot history.
Phloroglucinol’s key reactivity arises from ortho/para-directed electrophilic substitution and facile oxidation of the aromatic core. Condensation, etherification, and nucleophilic aromatic substitutions represent the most frequent downstream applications.
Industrial reactions typically occur under controlled acidic or basic conditions. Solvent and catalyst selection are driven by desired selectivity and impurity suppression. Temperature ranges are set to avoid decomposition or runaway glycol condensation which can reduce product yield.
Functionalization of phloroglucinol leads to a wide spectrum of derivatives in dye, perfumery, and pharmaceutical synthesis. Downstream transformations are sensitive to residual trace impurities and solvent residues; stringent purification upstream reduces side-reaction burdens in complex synthesis sequences.
Dry storage under low humidity and reduced temperature preserves product color and prevent hydrolytic degradation. Sensitive grades for diagnostics or pharmaceuticals require nitrogen-blanketed tanks or packs. Light exposure, especially UV, accelerates discoloration and formation of degradation byproducts in insufficiently packaged or clear-walled containers.
Container selection affects water pickup and contamination. HDPE drums or lined steel cans with tight sealing prevent ingress of atmospheric moisture and external volatiles. For high-purity or parenteral application, single-use barrier films and clean-room filling procedures reduce risk of contamination.
Shelf life is dictated by stowage environment: increases in moisture, oxygen, or light exposure shorten usable lifetime. Discoloration, caking, and odor development alert operators to onset of breakdown. End-users should be instructed on recognizing physical changes and verifying lot condition before use.
Hazard labeling reflects strong skin and eye irritation potential, especially for bulk handling and solution preparation. Dust inhalation risk is highest during loading and sifting operations. GHS statements and pictograms must align with both international and local regulations as interpreted by competent personnel.
Handling risk responds to exposure duration and form (dust vs. wet cake vs. solution). Engineering controls such as local exhaust, closed transfer, and PPE are prioritized on our sites. Operators report occasional sensitization from repeat contact; regular health monitoring and clear decontamination protocols are recommended.
Acute toxicity varies with route and dose, but all staff are briefed on proper avoidance and cleanup (spill management, first aid). Bulk packages feature clear, regulated labels detailing safe transfer and response to accidental contact. Occupational exposure limits and in-plant air monitoring are guided by risk assessment, grade-specific customer requirements, and regulatory updates.
Phloroglucinol production relies on batch-based synthesis, primarily using hydrolysis of trinitrophloroglucinol or selective reduction strategies, depending on raw material and environmental compliance requirements. Installed capacity varies due to the degree of vertical integration of precursor supply and access to stabilized intermediates. Over the past year, operating rates have fluctuated across facilities depending on scheduled maintenance, environmental audits, and procurement cycles, particularly in China and India, which are leading producers. Availability is sensitive to these operational variables. For high-purity pharmaceutical and electronic grades, custom batch runs can restrict immediate supply, lengthening effective lead time—especially during peak demand quarters.
Lead time for standard-grade phloroglucinol usually ranges from 2 to 4 weeks ex-works, contingent on material planning and order consolidation. Custom grades with stringent impurity thresholds or specialty packaging may require lead times extending up to 6-8 weeks, subject to additional analytical release. Minimum order quantity (MOQ) depends on grade, packaging, and intended use: technical and industrial grades generally observe lower MOQ, while pharmaceutical grade MOQs reflect the need for segregated production lines and compliance batch validation.
Packaging options include fibre drums lined with antistatic PE bags, sealed HDPE drums, and custom inert-gas flushed containers for material prone to degradation by moisture or air. Net weights typically range from 5 kg to 25 kg per primary container. Selection is driven by customer requirements, transit risk, and downstream handling protocols. Analytical and pharmaceutical grades often require tamper-evident packaging with full track-and-trace documentation.
Incoterms are negotiated depending upon destination and risk-sharing preferences. Most exports are shipped under FOB or CIF arrangements. Air freight is reserved for niche grades with high value per kg or for clinical trial requirements, due to the cost. Payment terms standardly use telegraphic transfer with partial advance, except for established accounts with an audited credit history. Changes in international trade compliance may require adjustment to terms for certain regions.
Raw material costs contribute the majority of phloroglucinol’s price volatility. Primary chemical precursors, such as resorcinol derivatives and reduction agents, account for most input variability. Fossil-derived feedstocks and energy for thermal steps directly affect unit cost. Utility fluctuations illustrate regional disparities, especially between China, India, and the EU. Secondary costs include maintenance of specialized reactors and handling protocols for controlled intermediates.
Market shocks in basic aromatic compounds, unexpected regulatory changes restricting certain nitro precursors, and energy supply interruptions (notably natural gas and coal price shifts) routinely drive input price instability. Environmental restrictions on hazardous waste management can tighten operating windows, pushing up per-kg costs in regulated regions. Seasonality in feedstock production also plays a minor role, particularly for biomass-adjacent supply chains.
Grade-specific formulation and release criteria create marked price tiers. Electronic and pharmaceutical grades, which demand sub-ppm impurity profiles and extensive identity confirmation protocols, require bespoke purification and carry higher costs. These releases involve additional batch documentation, chain-of-custody, and sometimes third-party analytical review. Packaging formats further affect cost: inert-atmosphere or contamination-controlled units command price premiums over bulk formats due to additional material and compliance checks. Certification against GMP, ICH Q7, or ISO standards introduces further cost strata, reflecting the regulatory and documentation burden.
Recent years have seen supply consolidation around large-scale Asian manufacturing hubs, with North America and Western Europe operating primarily as importers and formulators. Demand remains closely tied to the pharmaceutical sector, fluorescent dye synthesis, and advanced technical applications, including the electronics industry. Emergency shutdowns and raw material rationing at major Asian suppliers impact global spot price and contract renegotiation frequency.
- US and EU: Domestic production is minor and often restricted to custom synthesis, with reliance on imports from Asia. Regulatory compliance costs and shipping disruptions affect lead times and procurement planning. - Japan: High priority placed on ultra-pure grades for electronic and imaging applications. Long-term supplier agreements with detailed inspection requirements sustain price stability but limit volume flexibility. - China and India: Bulk production underpins global spot market liquidity. Environmental policy changes in China have introduced uncertainty in capacity utilization. India serves both technical and pharma segments, but production often hinges on reliable precursor imports and regulatory procedural consistency.
Ongoing regulatory tightening on aromatic nitro compound handling and waste management in China and the EU will continue to drive up compliance costs for producers. Volatility in energy and feedstock markets will keep input price ranges wide. Market expectation is for continued upward pressure on price for high-purity grades due to stringent downstream applications, while technical grade trends will reflect broader feedstock and energy cost movement. Data inputs include aggregated customs movement, industry publication price index tracking, and import/export documentation analysis from key global ports.
Restriction of nitro precursor imports in select Asian markets has driven increased coordination between downstream users and primary producers. Some markets have reported temporary shortages, especially of pharmaceutical grade material, following production halts for environmental inspection. Investment in closed-cycle waste management and solvent recovery has become prevalent in the top five Asian producers.
Enforcement of new waste management protocols and precursor registration schemes in China and India now requires all export batches to support enhanced documentation, including origin traceability and batch-level compliance affidavits. European Union importers are facing increased data requests under REACH as national authorities review aromatic intermediate registrations.
Manufacturers have expanded multi-step precursor quality-screening and upgraded reactor containment. Production scheduling increasingly builds in buffer for regulatory inspection and approval cycles. Cross-training of staff in compliance audit protocol is now part of standard operating procedure in high-purity production sectors.
Phloroglucinol serves as a key intermediate and active component across multiple sectors. In pharmaceutical synthesis, manufacturers rely on tight control of purity and residual solvents to ensure compatibility with downstream reactions and compliance with pharmacopoeial limits. The dye and pigment industry often uses technical grades, focusing less on trace impurity profiles and more on cost efficiency and suitability for large-scale formulation. In laboratories, research quality or analytical grades are chosen for consistent response in qualitative and quantitative analyses.
| Industry | Typical Grade | Critical Property Focus | Supplier Observations |
|---|---|---|---|
| Pharmaceutical API Synthesis | Pharmaceutical Grade | Purity, trace metals, residual solvents | Release batches meet cGMP and internal QC specs; highly controlled environment; each order tested for compendial and customer requirements |
| Dye & Pigment Manufacturing | Technical Grade | Color index, cost, solubility | Batches blended to maintain shade consistency; impurity control flexible based on downstream process tolerance |
| Analytical / Laboratory | Analytical/Reagent Grade | Purity, stability, lot-to-lot reproducibility | Batches traceable by CoA; packing in small units; evaluated against published test procedures |
| Fine Chemicals & Specialty Intermediates | Custom/Intermediate Grade | Solvent residue, particle size, specific impurity limit | Grade and packaging often customized per project; specification alignment defined in advance |
For pharmaceuticals, absolute content, moisture content, heavy metals, and solvent residues take priority due to their regulatory impact. For pigment and dye operations, product color, solubility profile, and non-interfering trace organics affect efficiency and product stability in end use. Laboratory and diagnostic use targets maximum reproducibility, as analytical errors trace back to reagent variability. Custom applications may prioritize one or more of these parameters, according to downstream chemical compatibility and performance target.
Production begins with a clear definition of the end use. Immediate downstream processes and application-specific standards drive initial grade selection. In-house technical teams and customer process chemists commonly clarify use scenarios during inquiry.
Client location and intended use often impose distinct compliance criteria, such as compliance with pharmacopeial monographs or regional chemical regulations. Regulatory teams review required certifications, and production routes may shift accordingly.
Technical grade suits processes tolerating wider impurity profiles, while pharmaceutical applications require thorough exclusion of controlled impurities. Purity impacts raw material cost, batch filtration needs, and traceability-throughout-production.
High-volume purchases for dye or chemical manufacturing usually set grade specifications for efficiency and price balance. Small-scale or high-purity batches receive added attention for consistency and packaging quality, with tailored batch sizes accounting for customer storage limits and expected throughput.
Sampling verifies property alignment with on-site process requirements. Internal labs provide batch-specific CoAs and can run side-by-side analysis with customer labs. This process uncovers tolerance limits for particle size, impurity profile, and solubility, where real-world performance remains the ultimate test.
Production of phloroglucinol requires real oversight from the ground up. Quality assurance covers both process control and final product handling. Manufacturing operations function under ISO-certified quality management systems, which ensure traceability from raw material intake to finished product release. Inspection schedules, batch documentation, and deviation management all receive attention under internal protocols shaped by industry best practices. Audits—both internal and by regulated third parties—drive corrective actions and reinforce the culture of compliance required for customers operating in tightly regulated end-uses such as pharmaceuticals and analytical chemistry.
Grade selection for phloroglucinol determines the certification set. Pharmaceutical and life science applications demand not just purity, but also documentation to back that claim. Regulatory compliance, including meeting pharmacopeia or REACH requirements, depends on the customer’s target market and the final application. Certification for GMP or other recognized standards applies where the batch is destined for critical-path use, and these batches undergo additional scrutiny during release. Certification packages differ by application needs and regional regulatory expectations, so communication about end-use helps predefine document assembly and release timing upstream.
Documentation provided routinely includes batch-specific Certificates of Analysis, supported by validated analytical data packages. Access to change control records and process validation summaries can be arranged when justified by customer audit or qualification needs. Product dossiers and full trace records for each lot allow regulatory submissions and help customers align with their own compliance obligations. Additional support documentation, such as origin tracking, impurity profiling, and process route declarations, can be appended by prior arrangement for customers in regulated industries.
Long-term supply planning rests on predictable production schedules and a robust supply chain for raw materials. Production volumes scale by grade breakdown and contract commitments. Multi-shift operations and reserve equipment capacity allow for surge demand and new program onboarding. Contractmanufacturing or spot purchases integrate with established planning, but advance scheduling ensures raw material supply and technical support staffing.
Raw material sourcing relies on dual-vendor strategies; critical materials undergo incoming quality verification, which minimizes bottleneck risk in the upstream. The core production units maintain buffer inventory based on forecasted demand swings to ensure consistent batch output. Responsive logistics support, including in-house and contracted warehousing, allows for short transit times to regional or export customers, dependent on the mode of dispatch and packaging configuration.
Sample requests undergo internal technical assessment to confirm the application scenario and regulatory burden. Each request initiates batch selection from existing production lots that match the grade and analysis requirements. Standard sample packs ship with provisional Certificates of Analysis and route-appropriate transport logistics. Prequalification batches can be arranged as test runs, subject to lead time for manufacturing and analysis. Details of analyte content and impurity profile can be discussed directly between technical service and customer R&D.
Supply agreements adjust for volume, replenishment logic, and contract length: from fixed schedule shipments with locked-in volume pricing to call-off arrangements with agreed buffer stocks. Demand spikes or program changes handled by advance notice terms. Integrated technical support becomes available for customers requiring documentation for registration or scale-up process evaluation. Risk-sharing models, such as consignment stock or phased delivery, support complex or regulated project timelines. All cooperation options rest on transparent communication and documented expectations, structured to minimize disruption and match customer operational models.
Development in phloroglucinol production focuses on optimizing synthetic efficiency and total impurity control, especially with rising demand from pharmaceutical, chemical, and analytical end-users. Researchers are investigating improved process catalysis to reduce hazardous byproducts, alongside alternative feedstocks that enable lower energy consumption and fewer downstream contaminants. Analytical laboratories request higher purity specifications, pushing our development teams to refine recrystallization steps and to design tailored purification modules for each production route.
Phloroglucinol continues finding roles in synthetic chemistry beyond its classical pharmaceutical and dye intermediate uses. Custom resin manufacturing now requests specific grades for condensation reactions in advanced materials. Research in life sciences identifies its potential in new diagnostic kits, triggering technical collaboration on unique formulating properties. Fluctuations in market demand often trace back to discoveries in these specialty segments, as downstream manufacturers test alternative uses for its polyvalent aromatic structure.
Key industrial hurdles include minimizing trace-level organic residuals and achieving uniform batch reactivity. Upstream raw material variability remains a persistent point for quality assurance, with both chemical and biological feedstocks presenting distinct impurity profiles. Persistent efforts in analytical method development – chiefly in HPLC and MS-based trace analysis – have improved release test reliability for both bulk and high-purity grades. Recent breakthroughs in solvent management lowered trace metal contamination, especially important for grades destined for API synthesis.
Industry forecasts anticipate steady growth in the next five years, supported by demand from both established pharmaceutical synthesis and expanding fine chemical applications. Clients require more flexible batch sizes and diversified packaging as their logistics evolve. The dynamic regulatory landscape surrounding intermediate chemicals also drives consistent requests for documentation support and traceability, adding value through detailed certifiable release profiles.
Continuous improvement in continuous flow processes is changing cost structures, particularly where environmental emissions and solvent recovery can be engineered at source. Automation and remote monitoring solutions integrate directly into plant operations, reducing human error in batch-to-batch transition. Inline PAT (Process Analytical Technology) modules now permit real-time monitoring of key production stages, ensuring the impurity profile remains within client and regulatory specifications before batch release.
Efforts to reduce the environmental impact direct research into alternative green solvents and waste minimization. Adoption of closed-loop water systems in purification and solvent recovery reduces resource draw and regulatory exposure. Selection of catalysts with higher selectivity both diminishes the raw material demand and cuts down on non-target byproduct formation, echoing the sector’s drive toward circular manufacturing and verifiable ecological compliance. Technical teams also prioritize lifecycle product documentation to support downstream users in eco-audits.
Direct manufacturer support underpins every technical consultation service. Production chemists and QA specialists assist clients in mapping actual analytical requirements and discuss potential grade-up or process route options. Responses to customer queries draw from firsthand batch history, process logbooks, and in-house analytical archives, rather than relying on generic supplier libraries.
Application engineers work directly with formulators to adjust product parameters for specific downstream performance—whether tightening limits on residual solvents, optimizing particle size, or customizing flowability for automated bulk handling. For highly regulated end-uses, support teams interpret analytical data in the context of both manufacturing route and customer validation needs. When a customer’s process shows shift in reactivity or unexpected residues, collaboration includes tracing raw material origin and isolating points for on-site adjustment.
Manufacturer’s after-sales commitment extends from continuous documentation updates to direct troubleshooting support on product shipment and storage anomalies. Typical responses track root causes back to production and transit chain, involving QA, logistics, and technical teams. Recurring issues prompt process review meetings, ensuring both customer and production side insights feed into updated control plans. Batch traceability records and QC archives are maintained to ensure both regulatory and customer-specific audit readiness.
Our facility produces phloroglucinol by direct synthesis, following established protocols under tightly managed plant conditions. Every phase of processing, from raw material selection to final filtration, runs under controlled parameters. Each batch moves through our proprietary multi-step purification process. This gives industrial buyers a clear advantage: every shipment draws from a core process engineered for lot-to-lot reproducibility. Only batches that meet pre-set chromatographic and purity checks are released to finished goods. Analytical data accompanies every drum, providing documented assurance of compliance with relevant technical requirements.
Phloroglucinol functions as a core intermediate for API manufacturing in the pharmaceutical industry, offering reliable building block chemistry for downstream synthesis. Dye and pigment manufacturers use it as a key aromatic scaffold, and companies operating in photoproducts and specialty chemicals demand it for its versatile reactivity and performance in custom transformations. These users depend on consistent molecular structure and minimum byproduct background, both tightly monitored in our production runs. Our technical team addresses process inquiries typical of R&D and scale-up operations, supporting smooth integration into both new and legacy manufacturing routes.
Every plant run undergoes frequent in-process controls for purity, melting range, and critical trace impurities. All analyses originate from our in-house QC laboratory, equipped for advanced instrumental testing including HPLC, GC, and FTIR. Incoming raw materials come under routine elemental screening prior to processing. Full traceability covers each batch from reception through to finished goods. Our consistent output helps minimize production delays for industrial users by removing variability at the source. Product certificates cite actual analytical figures for key specifications, not just “typical” results.
Phloroglucinol ships in multiple formats, including fiber drums, steel containers, and custom bulk packaging designed for industrial handling. Each shipment uses packaging that aligns with specific transport, storage, and health regulations common to major markets. Large-scale users benefit from bulk delivery schedules managed under long-term supply programs, reducing inventory hold points and improving production planning. In the event of critical demand peaks, plant capacity and raw material reserves support short lead time shipments. Lot tracking remains visible across every stage of the logistics process, supporting inventory management at the customer site.
In-house application specialists work closely with process engineers and chemists at client facilities. Support covers troubleshooting during trial phases, guidance on storage stability, and recommendations for downstream compatibility. This partnership approach results in stronger process yields and improved product reproducibility for our business partners. Our role continues beyond delivery, addressing any technical questions arising in formulation or process upgrades. Documentation, including certificates of analysis and regulatory information, is provided to back rigorous qualification processes demanded by most industrial users.
Direct factory supply eliminates layers of sourcing uncertainty and communication delays. Procurement teams control costs through large-volume negotiations and multi-year contracts backed by firm production capacity. Distributors receive material with full provenance, simplifying onward compliance and resale documentation. Processing plants gain reliability in input supply, bolstered by access to technical support and production planning resources. Our commitment to consistency, technical expertise, and reliable delivery directly supports lean manufacturing outcomes and supply chain resilience across industries.
Phloroglucinol shows up regularly across pharmaceuticals, dye manufacturing, analytical chemistry, and plant tissue culture. Consistent product quality starts at the raw material source and extends through reaction control to the finished product. Our in-house protocols chase purity and reliability because inconsistent material leads to process headaches and unreliable downstream performance.
Phloroglucinol, chemically named 1,3,5-trihydroxybenzene, has a molecular formula of C6H6O3 and a molar mass of 126.11 g/mol. Our typical manufacturing batches produce a pale-yellow crystalline solid. The compound melts close to 220°C (decomposition often occurs at the melting point), and it dissolves well in water, methanol, and ethanol. Solubility ranks highly for formulating aqueous solutions in process or application areas, notably for clinical or analytical preparations.
The structure’s three hydroxyl groups give strong reactivity. In actual factory practice, this means moisture control and packaging integrity matter; the compound’s hygroscopic nature leads us to use moisture barrier liners for all packaging. Repeated shelf tests by our QC group underscore that even short-term exposure to humidity breaks down stability. Chemical reactivity also requires all equipment to use corrosion-resistant materials.
Quality benchmarks cut out doubt and rework. We run rigorous HPLC and titration tests for purity. Our assay specification for Phloroglucinol sits at ≥99% on a dry basis, with every batch checked both during in-process sampling and on final product release. Impurity levels—particularly benzene ring isomers or unreacted intermediates—face strict upper limits as set by pharmacopoeial references or direct customer standards. Control of residual solvents, usually ethanol or water from our synthesis process, gets certified below threshold ppm levels.
Our moisture content specification typically lands below 0.5%, as measured with Karl Fischer titration. Even slightly higher water content can lower product shelf life and trigger clumping, which causes problems for end users who require free-flowing material. We calibrate instruments daily, as even minor drift can mask a deviation from the spec, and deviations get flagged for batch rejection or reprocessing.
Analytical consistency helps eliminate uncertainty for clients scaling recipes or pharmaceutical formulations. Our approach combines automated process controls with manual observation—because in our experience, seasoned technicians often pick up subtle off-notes that sensors miss, especially during crystallization and drying.
Color, odor, and trace contamination represent frequent audit targets as well. Our QA team observes a faint phenolic aroma, and any off-color or foreign particulate draws immediate attention. Particle sizing—though not always requested—has become more common as our customers automate their own handling systems. We sample every drum, record retention samples, and verify traceability from raw material forward.
Process simplicity rarely wins in specialty chemicals. We invest in purification steps and secondary drying cycles to chase minimal impurity content and consistent finished product texture. Our team remains accessible for on-site technical audits or to run customer sample lots. If clients require tailored moisture, granularity, or packaging, we offer batch-level adjustments to hit their technical and operational targets.
Our experience shows that well-documented process control paired with transparency results in higher confidence, less downtime, and fewer product returns. Long-term partnerships with raw material suppliers and a pipeline of ongoing QC method development drive our reliability as a direct manufacturer. On request, we provide full assay documentation, impurity profile, heavy metals data, and stability testing records with every shipment of Phloroglucinol.
At the heart of our operations, production planning always takes shape from real-market planning, not salesman theory. As direct manufacturers of phloroglucinol, we understand one practical truth: customers need clarity about minimum order requirements and lead times before scheduling their own projects. Without this information upfront, downstream production stalls, lab work gets delayed, and even shipping arrangements can turn into a game of guesswork.
Batch synthesis drives production economics for phloroglucinol. Each batch requires labor, raw input, reactor time, and rigorous quality checks. For this reason, we have calculated our minimum order quantity to align with efficiency on one side and waste reduction on the other. Typically, the minimum order quantity centers around a single manufacturing batch. This allows us to keep costs competitive for both laboratory-scale and larger requirements, and to ensure material is always fresh from our reactors, not sitting idle in storage. Smaller runs rarely keep pace with rational production costs, so bulk processing delivers consistency for end users, not just our own bottom line.
Most customers regularly purchase phloroglucinol for applications in pharmaceuticals, spectroscopy, and dyes. Based on industry demand, our minimum order usually starts at the equivalent of an industrial drum or several sealed containers, sufficient for typical R&D as well as upscaling trials. Orders falling short of batch scale often end up costing more per kg and take up valuable production time that we could use to serve customers planning for standard runs. By keeping our minimum order at a practical level, we stabilize both our factory workload and clients’ supply forecasting. Our sales and logistics managers work together to match minimum sizes with frequent customer needs and current raw material pricing.
Our production calendar never stands still. At peak demand, phloroglucinol slots can fill quickly, especially before shutdown or after holidays. We build lead times around our pipeline for raw input availability, laboratory-scale benchwork, full-scale batch processing, and in-house analytical testing — not just blending or packaging. Every single kilogram undergoes packaging right here in the same complex under strict GMP procedures. Materials move from reactor to QC, onward to the warehouse, then packed according to volume and shipping regs for hazardous materials where relevant.
Typical lead time averages several weeks from order confirmation. This window covers everything from procurement of vital precursors, through batch manufacturing and post-processing, to QA review and shipment preparation. For repeat clients with annual forecasts, we offer scheduled production slots to trim timelines. Emergency or rush orders face constraints if critical raw materials or production vessels are already locked for other jobs. During supply volatility, such as global logistics disruption or raw input scarcity, advance booking protects customers from delay.
Plant maintenance, regulatory inspection cycles, and fluctuations in raw material pricing sometimes introduce extra complexity. We keep our customers informed about temporary adjustments to minimum order size or lead time due to planned shutdowns or validation runs. On rare occasion, volatile demand or policy changes affect export documentation, but our team stays in close communication from initial inquiry to final shipment. We provide detailed order and batch tracking, and technical support through every step, because good chemistry relies on more than just product — it depends on clear communication and realistic supply planning.
Phloroglucinol ranks among those specialty chemicals that call for a serious approach right from production to customer delivery. In our experience manufacturing this compound at scale, safe handling starts long before it ever leaves our facility gate.
We store phloroglucinol in tightly-sealed, clean containers—usually high-grade fiber drums with an inner polyethylene liner—to prevent contamination and moisture ingress. Water can trigger decomposition or clumping, so our warehouse maintains dry conditions, usually below 25°C, with good air circulation and away from incompatible materials. Since light can cause degradation, we keep containers inside closed racks, never in direct sunlight. Any spilled material goes straight into a designated waste collection, handled by trained staff using suitable personal protection.
During transit, it’s critical to shield phloroglucinol from physical shock and environmental conditions. Our standard packaging meets UN recommendations for hazardous chemicals, often certified as suitable for land and sea freight. Labels on each drum carry the right hazard statements, warnings, and batch identification for traceability. Shipping paperwork always matches up with transport regulations such as IMDG for waterways or DOT for U.S. ground shipments. Any carrier we use must demonstrate competence in handling regulated substances and comply with all documentation rules. Pallets are wrapped for extra security, minimizing any risk of drum puncture or accidental opening.
Handling phloroglucinol involves several compliance steps. Our manufacturing and outbound logistics teams comply with both local and international chemical management rules, including REACH for export to Europe and TSCA for the U.S. Each shipment travels with an updated Safety Data Sheet, and all documentation reflects the correct hazard codes per GHS (Globally Harmonized System). In practice, this means routine review of both packaging and workplace protection procedures by our safety team, since authorities can inspect documentation and physical controls any time. Any regulations concerning restricted chemicals in customer territories factor directly into our logistics and regulatory workflows.
Nothing replaces experience, especially with chemicals like phloroglucinol. Our technical support staff work with logistics to review any special customer requirement, such as temperature-controlled transport if needed. Should a delay or incident occur, internal protocols dictate immediate incident reporting, both for regulatory reasons and for traceability back through our batch records. As the manufacturer, we address every step—no outside party takes responsibility for our product’s handling or compliance. This reduces the risk of cross-contamination and guarantees consistent product quality for demanding analytical or pharmaceutical clients.
Challenges such as tighter export controls or evolving hazard classifications prompt regular changes at the factory and in our process flows. We reinforce training for staff working in the warehouse and dispatch, updating them whenever safety data sheets are revised. Efficiency gains in packaging help keep accidental release risks low while still keeping costs manageable for buyers. Should new data become available—say, a transportation authority updates permitted packaging types—we are quick to align, updating protocols and informing supply chain partners immediately. This direct oversight lets us keep every batch safe and compliant, from blending to final delivery.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@alchemist-chem.com, +8615371019725 or WhatsApp: +8615371019725
